Furthermore, numerous studies using various models have suggested that CTSB would be beneficial to AD and PD by reducing Aβ and α-synuclein accumulation respectively, due to autophagy and lysosome-related functions of CTSB in the brain [107,108,109,110,111,112]. Here, SNCA is linked to Parkinson disease.